AGENDA

Official title: Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients – A randomized placebo-controlled trial

Trial start year: 2007

Trial website

No website available

Trial registration

NCT00386841
View registration
Design paper

Design paper

2009

Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression
Download full paper
Result paper

Result paper

2011

Escitalopram and Neuroendocrine Response in Healthy First-Degree Relatives to Depressed Patients – A Randomized Placebo-Controlled Trial
Download full paper